AI-driven advancements in electronic skin technology promise revolution in health monitoring and diagnostics

Review discusses the integration of AI in developing next-generation e-skin, focusing on engineering challenges, signal processing, and health data analysis for applications in human-machine interfaces and disease diagnosis.

Eli Lilly, Pfizer stress independence of telehealth partners in response to senators

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 4, 2024

Clinical trial launched to explore new drug treatments for military personnel and veterans with PTSD

A groundbreaking clinical trial launched October 16 will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder

October 26, 2023

Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Admission/Miscellaneous Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202,

September 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.